Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07671417
EARLY_PHASE1
Imaging Study of a CAIX Binder in Metastatic Clear Cell RCC.
Sponsor: RayzeBio, Inc.
View on ClinicalTrials.gov
Summary
This imaging study aims to assess the feasibility, biodistribution, and dosimetry of a novel Carbonic Anhydrase IX (CAIX) Binder in Subjects with Metastatic Clear Cell Renal Cell Cancer (RCC).
Official title: A Phase 0 Imaging Study to Assess the Feasibility, Biodistribution, and Dosimetry of a Carbonic Anhydrase IX (CAIX) Binder in Subjects With Metastatic Clear Cell Renal Cell Cancer (RCC).
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2026-06
Completion Date
2027-01
Last Updated
2026-06-26
Healthy Volunteers
No
Interventions
DIAGNOSTIC_TEST
RYZ512
Imaging Agent
Locations (1)
Research Facility
Christchurch, New Zealand